Rizatriptan shortage — NZ supply status & alternatives

Rizatriptan

ATC N02CC04

🇦🇺 AUST R 407853

In supply · Australia

Apo-Rizatriptan

In supply · 🇦🇺 Australia · short in🇨🇦 CA🇪🇸 ES🇮🇹 IT🇳🇿 NZ

In supply in Australia

Reading today’s signals…

🇦🇺 AUAEMPA$4.00DPMQ A$22.84details →

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

Zolmitriptan

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Rizatriptan
Brand names	Apo-Rizatriptan
ATC level 5	N02CC04
ATC level 4	N02CC
Therapeutic category	Auto-created by Health Canada — Drug Shortages Database scraper
Controlled substance	No
Marketing-authorisation holders	ACCORD-UK LIMITED, SANDOZ LIMITED, TILLOMED LABORATORIES LIMITED, MILPHARM LIMITED +5 more
Registrations on file	22
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$4.00

AEMP

Dispensed (DPMQ)

A$22.84

incl. fees

Pack

rizatriptan 10 mg orally disintegrating tablet, 2

Source: PBSEffective July 2026 · AUD

Other markets

🇬🇧 GB

£8.18

concession

🇮🇹 IT

€8.28

Retail price

🇫🇷 FR

€19.19

Retail price

🇪🇸 ES

€26.40

Retail price

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

18 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Emcure Pharmaceuticals LTDAlivus Life Sciences LTDZhejiang Supor Pharmaceuticals CO LTDCipla LTDMatrix Pharmacorp Private LTDDr Reddys Laboratories LTD+12 more

Manufacturing countries: India, China, Spain, Taiwan · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders22 registrations · 9 MA holders

Product	Strength	Form	Market	MA holder	Status
MAXALT MIGRAINE RELIEF rizatriptan	5 mg	—	🇦🇺 AU	—	Active
Odt-Wgr	10 mg	—	🇦🇺 AU	—	Active
RIZATRIPTAN 10MG ORODISPERSIBLE TABLETS	10MG	tablet	🇬🇧 GB	ACCORD-UK LIMITED	Active
RIZATRIPTAN 5MG ORODISPERSIBLE TABLETS	5MG	tablet	🇬🇧 GB	SANDOZ LIMITED	Active
Apo	5 mg	—	🇦🇺 AU	—	Active
RIZATRIPTAN 10 MG ORODISPERSIBLE TABLETS	10 MG	tablet	🇬🇧 GB	TILLOMED LABORATORIES LIMITED	Active
Rizatriptan Tillomed	10 MG	tablet	🇬🇧 GB	TILLOMED LABORATORIES LIMITED	Active
RIZATRIPTAN 5 MG ORODISPERSIBLE TABLETS	5 MG	tablet	🇬🇧 GB	TILLOMED LABORATORIES LIMITED	Active
Rizatriptan Tillomed	5 MG	tablet	🇬🇧 GB	TILLOMED LABORATORIES LIMITED	Active
RIZATRIPTAN 5 MG TABLETS	5 MG	tablet	🇬🇧 GB	MILPHARM LIMITED	Active
RIZATRIPTAN 10 MG TABLETS	10 MG	tablet	🇬🇧 GB	MILPHARM LIMITED	Active
RIZATRIPTAN 5MG TABLETS	5MG	tablet	🇬🇧 GB	GLENMARK PHARMACEUTICALS EUROPE LIMITED	Active
RIZATRIPTAN 10MG TABLETS	10MG	tablet	🇬🇧 GB	GLENMARK PHARMACEUTICALS EUROPE LIMITED	Active
RIZATRIPTAN 10MG ORODISPERSIBLE TABLET	10MG	tablet	🇬🇧 GB	GLENMARK PHARMACEUTICALS EUROPE LIMITED	Active
Rizatriptan Neuraxpharm	10 MG	tablet	🇬🇧 GB	NEURAXPHARM UK LIMITED	Active

+7 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.